Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation

• Publication date

  2002-04-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000012467.61045.87PMID 11956132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertensive diabetic cardiomyopathy in the rat: ultrastructural features

  2004cited by this paper
• Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir

  2004cited by this paper
• A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels

  2002cited by this paper
• Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities: The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association.

  2001cited by this paper
• Effect of Non–Insulin-Dependent Diabetes Mellitus on Myocardial Insulin Responsiveness in Patients With Ischemic Heart Disease

  2001cited by this paper
• Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

  2001cited by this paper
• Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction

  2001cited by this paper
• Diseases of liporegulation: new perspective on obesity and related disorders

  2001cited by this paper
• New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

  2001cited by this paper
• Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart

  2001cited by this paper
• Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids.

  2001cited by this paper
• Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation.

  2001cited by this paper
• Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc

  2001cited by this paper
• [5-3H]glucose overestimates glycolytic flux in isolated working rat heart: role of the pentose phosphate pathway.

  2001cited by this paper
• Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis

  2001cited by this paper
• A novel mouse model of lipotoxic cardiomyopathy.

  2001cited by this paper
• Palmitate-induced Apoptosis Can Occur through a Ceramide-independent Pathway*

  2001cited by this paper
• Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart*

  2001cited by this paper
• Modulation of cardiac sarcoplasmic reticulum gene expression by lack of oxygen and glucose

  2001cited by this paper
• Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro.

  2001cited by this paper
• Role of reactive oxygen species (ROS) in apoptosis induction

  2000cited by this paper
• Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

  2000cited by this paper
• Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb

  2000cited by this paper
• Insulin resistance in chronic heart failure.

  2000cited by this paper
• Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.

  2000cited by this paper
• PPAR signaling in the control of cardiac energy metabolism.

  2000cited by this paper
• CAP defines a second signalling pathway required for insulin-stimulated glucose transport

  2000cited by this paper
• Lipotoxic heart disease in obese rats: implications for human obesity.

  2000cited by this paper
• Impact of diabetes on cardiac structure and function: the strong heart study.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

  2000cited by this paper
• Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.

  2000cited by this paper
• Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell.

  2000cited by this paper
• Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell*

  2000cited by this paper
• Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction.

  2000cited by this paper
• Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside*

  2000cited by this paper
• Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.

  2000cited by this paper
• Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.

  2000cited by this paper
• Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.

  2000cited by this paper
• Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance.

  2000cited by this paper
• Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

  2000cited by this paper
• Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply.

  2000cited by this paper
• Redox Regulation of Cardiac Muscle Calcium Signaling

  2000cited by this paper
• Signaling pathways in insulin action: molecular targets of insulin resistance.

  2000cited by this paper
• Glucose Regulation of Gene Transcription*

  2000cited by this paper
• Myocardial Cell Death in Human Diabetes

  2000cited by this paper
• Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes.

  2000cited by this paper
• Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.

  2000cited by this paper
• Regulation of gene expression by dietary fat.

  1999cited by this paper
• Signaling Mechanisms That Regulate Glucose Transport*

  1999cited by this paper
• Regulation of gene expression by glucose

  1999cited by this paper
• Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes.

  1999cited by this paper
• Signaling pathways for cardiac hypertrophy and failure.

  1999cited by this paper
• Impaired Cardiac Performance in Heterozygous Mice with a Null Mutation in the Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2 (SERCA2) Gene*

  1999cited by this paper
• Induction

  1999cited by this paper
• Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate*

  1999cited by this paper
• Malonyl-CoA, fuel sensing, and insulin resistance.

  1999cited by this paper
• AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes.

  1999cited by this paper
• Malonyl-CoA, fuel sensing, and insulin resistance.

  1999cited by this paper
• Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

  1999cited by this paper
• Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.

  1999cited by this paper
• Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  1999cited by this paper
• Transcriptional modulators targeted at fuel metabolism of hypertrophied heart.

  1999cited by this paper
• Myofibroblasts. I. Paracrine cells important in health and disease.

  1999cited by this paper
• alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart.

  1999cited by this paper
• Diabetes mellitus and congestive heart failure. Further knowledge needed.

  1999cited by this paper
• Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene*

  1999cited by this paper
• Signaling in myocardial hypertrophy: life after calcineurin?

  1999cited by this paper
• A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.

  1999cited by this paper
• Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes

  1999cited by this paper
• Glucose for the heart.

  1999cited by this paper
• Glucose regulation of gene expression.

  1998cited by this paper
• Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM

  1998cited by this paper
• Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: Prevention by α-tocopherol?

  1998cited by this paper
• Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

  1998cited by this paper
• Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

  1998cited by this paper
• Cellular mechanisms of cardiac hypertrophy

  1998cited by this paper
• Maturation of fatty acid and carbohydrate metabolism in the newborn heart

  1998cited by this paper
• Subcellular remodeling and heart dysfunction in chronic diabetes.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Evidence for 5′AMP-Activated Protein Kinase Mediation of the Effect of Muscle Contraction on Glucose Transport

  1998cited by this paper
• AMP-activated Protein Kinase Inhibits the Glucose-activated Expression of Fatty Acid Synthase Gene in Rat Hepatocytes*

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Isolated Postchallenge Hyperglycemia and the Risk of Fatal Cardiovascular Disease in Older Women and Men: The Rancho Bernardo Study

  1998cited by this paper
• Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.

  1998cited by this paper
• Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α*

  1998cited by this paper
• Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo.

  1998cited by this paper
• Dual regulation of the AMP‐activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle

  1998cited by this paper
• Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

  1998cited by this paper
• Regulation of Energy Metabolism of the Heart during Acute Increase in Heart Work*

  1998cited by this paper
• Fatty acid-induced β cell apoptosis: A link between obesity and diabetes

  1998cited by this paper
• Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Function by Mitogen-activated Protein Kinase*

  1997cited by this paper
• Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes.

  1997cited by this paper
• Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility

  1997cited by this paper
• Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group.

  1997cited by this paper
• Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat.

  1997cited by this paper
• Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion.

  1997cited by this paper
• A Molecular Basis for Insulin Resistance

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

  1997cited by this paper
• Gender and acute myocardial infarction: is there a different response to thrombolysis?

  1997cited by this paper

• Regenerative therapies for myocardial infarction: exploring the critical role of energy metabolism in achieving cardiac repair

  2025cites this paper
• Acute Arrhythmias in a Long-chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD) Mouse Model.

  2025cites this paper
• Endothelial cell-cardiomyocyte cross-talk: understanding bidirectional paracrine signaling in cardiovascular homeostasis and disease.

  2024cites this paper
• Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.

  2024cites this paper
• Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Cardiac Remodeling and Ventricular Pacing: From Genes to Mechanics

  2024cites this paper
• Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes.

  2024cites this paper
• Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction

  2024cites this paper
• Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy

  2023cites this paper
• DIABETES MELLITUS AND CONCURRENT RENAL INSUFFICIENCY AS PROGNOSTIC INDICATORS FOR ACUTE MYOCARDIAL INFARCTION

  2023cites this paper
• The neurometabolic axis: A novel therapeutic target in heart failure.

  2023cites this paper
• "Subclinical right ventricular dysfunction in patients with asymptomatic type 2 diabetes mellitus: A cross-sectional study".

  2023cites this paper
• DNA damage and nuclear morphological changes in cardiac hypertrophy are mediated by SNRK through actin depolymerization

  2023cites this paper
• DNA Damage and Nuclear Morphological Changes in Cardiac Hypertrophy Are Mediated by SNRK Through Actin Depolymerization

  2023cites this paper
• Is increased myocardial triglyceride content associated with early changes in left ventricular function? A 1H-MRS and MRI strain study

  2023cites this paper
• Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues

  2022cites this paper
• Functions and origins of cardiac fat

  2022cites this paper
• The effects of G protein-coupled receptor 30 (GPR30) on cardiac glucose metabolism in diabetic ovariectomized female rats

  2022cites this paper
• Association of continuous positive airway pressure therapy on cardiac hypertrophy in patients with sleep apnea comorbid with type 2 diabetes mellitus.

  2022cites this paper
• Strategies for Imaging Metabolic Remodeling of the Heart in Obesity and Heart Failure

  2022cites this paper
• Comprehensive assessment of biventricular myocardial function by two-dimensional speckle tracking echocardiography in infants of gestational diabetic mothers

  2022cites this paper
• Mechanisms and implications of sex differences in cardiac aging

  2022cites this paper
• SIRPα Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease

  2022cites this paper
• Maladaptations

  2021cites this paper
• Circadian rhythms in cardiac metabolic flexibility

  2021cites this paper
• Validity of QRS Configuration and Myeloperoxidase Level as Determinants of CAD Severity and Prognosis in Patients with STEMI

  2021cites this paper
• Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population

  2021cites this paper
• Electron Microscopy Revealed Massive Lipid Droplets in Cardiomyocytes in a Patient with Cardiogenic Shock Following a Fulminant Type 1 Diabetes Mellitus.

  2021cites this paper
• A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates

  2021cites this paper
• Heart Failure in Diabetes: Still a Vexing Problem.

  2021cites this paper
• Adaptation of the cardiovascular system of infants born by mothers with diabetes mellitus

  2021cites this paper
• Impact of obesity on day‐night differences in cardiac metabolism

  2021cites this paper
• Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes

  2021cites this paper
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• The role of diabetes mellitus in diseases of the gallbladder and biliary tract.

  2020cites this paper
• Involvement of Heparanase in Endothelial Cell-Cardiomyocyte Crosstalk.

  2020cites this paper
• Positioning Metabolism as a Central Player in the Diabetic Heart

  2020cites this paper
• Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

  2020cites this paper
• Cardiac ketone body metabolism.

  2020cites this paper
• Strategies of Unloading the Failing Heart from Metabolic Stress.

  2020cites this paper
• The Potential Role of Undercarboxylated Osteocalcin Upregulation in Microvascular Insufficiency in a Rat Model of Diabetic Cardiomyopathy

  2020cites this paper
• Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes

  2020cites this paper
• Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a “Switch” to the Foetal Gene Programme

  2020cites this paper
• Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways.

  2019cites this paper
• Exercise Metabolism in Health and Disease

  2019cites this paper
• Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date

  2019cites this paper
• Heart Failure and Metabolic Factors

  2019cites this paper
• Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte

  2019cites this paper
• Effects of Exercise to Improve Cardiovascular Health

  2019cites this paper
• Diabetic Cardiomyopathy Pathophysiology and Update on Treatment

  2019influential citation
• Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches

  2019cites this paper
• Unresolved issues in left ventricular postischemic remodeling and progression to heart failure.

  2019cites this paper
• Contemporary approach to treating heart failure.

  2019cites this paper
• Mechanisms of protective effects of SGLT2 inhibitors in cardiovascular disease and renal dysfunction.

  2019cites this paper
• Carbonic anhydrase II/sodium-proton exchanger 1 metabolon complex in cardiomyopathy of ob-/- type 2 diabetic mice.

  2019cites this paper
• Maladaptations

  2019cites this paper
• Myocyte [Na⁺]_i Dysregulation in Heart Failure and Diabetic Cardiomyopathy

  2019cites this paper
• Metabolic Risk Factors and Left Ventricular Diastolic Function in Middle‐Aged Chinese Living in the Tibetan Plateau

  2019cites this paper
• Diabetes and Cardiovascular Disease

  2019cites this paper
• The Impact of Type 2 Diabetes Mellitus on Long-Term Prognosis in Patients of Different Ages with Myocardial Infarction

  2018cites this paper
• Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management.

  2018cites this paper
• Metabonomics Indicates Inhibition of Fatty Acid Synthesis, β-Oxidation, and Tricarboxylic Acid Cycle in Triclocarban-Induced Cardiac Metabolic Alterations in Male Mice.

  2018cites this paper
• Prevalence of Subclinical Left Ventricular Diastolic Dysfunction in Patient with Metabolic Syndrome in West Region of the Republic of acedonia

  2018cites this paper
• Prevalence of Subclinical Levt Ventricular Diastolic Dysfunction in Patient with Metabolic Syndrome in West Region of the Republic of Macedonia

  2018cites this paper
• Cardiovascular Implications of Diabetes, Metabolic Syndrome, Thyroid Disease, and Cardio-Oncology in Women.

  2018cites this paper
• An Interrelationship betweenNt Pro-Bnp Level, Glycemic Control And Myocardial Ischemia in Type 2 Diabetes Without Overt Cardiac Disease

  2018cites this paper
• Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance

  2018cites this paper
• Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose

  2018cites this paper
• Possibility of a New Therapeutic Strategy for Left Ventricular Dysfunction in Type 2 Diabetes

  2018cites this paper
• Myocyte [Na+]i Dysregulation in Heart Failure and Diabetic Cardiomyopathy

  2018cites this paper
• Metabolic Effects of Metformin in the Failing Heart

  2018influential citation
• [At the heart of diabetic cardiomyopathy: Bscl2 knockout mice to investigate glucotoxicity].

  2018cites this paper
• Imaging myocardial metabolism

  2018cites this paper
• SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials

  2018cites this paper
• Diabetes mellitus type 2 and acute myocardial infarction: prognostic options for interaction in patients of different age groups

  2018cites this paper
• Streptozotocin‐induced type II diabetic rat administered with nonobesogenic high‐fat diet is highly susceptible to myocardial ischemia–reperfusion injury: An insight into the function of mitochondria

  2018influential citation
• Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy

  2018cites this paper
• VEGF-B: friend or foe to the heart in times of nutrient excess?

  2017cites this paper
• Dissipative energy loss within the left ventricle detected by vector flow mapping in diabetic patients with controlled and uncontrolled blood glucose levels

  2017cites this paper
• The changes of fructos-2,6-bisphosphate level in transgenic mice causing cardiomyopathy

  2017cites this paper
• The pathophysiological basis of the protective effects of metformin in heart failure.

  2017cites this paper
• The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model

  2017cites this paper
• Trimetazidine in conditions other than coronary disease, old drug, new tricks?

  2017cites this paper
• Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients.

  2017cites this paper
• Facile Enzymatic Synthesis of Ketoses and Chemoenzymatic Reporter Strategy for Probing Complex Glycans

  2017cites this paper
• Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus

  2017cites this paper
• Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective

  2017cites this paper
• Metformin HCl has curative effect on rebuilding of ventricular diastolic functions in high-fat-diet fed rats.

  2017cites this paper
• Effect of Uncontrolled Diabetic Dyslipidemia in the Prevalence of Sub-Clinic Left-Ventricular Diastolic Dysfunction in Western Region of the Republic of Macedonia Atila Journal of Research in Diabetes & Metabolism

  2017cites this paper
• Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

  2017cites this paper
• A Study of Comparison of Left Ventricular Mass in Hypertensive Patients With Diabetes Mellitus and Without Diabetes Mellitus

  2017cites this paper
• Markers of Maternal and Infant Metabolism are Associated with Ventricular Dysfunction in Infants of Obese Women with Type 2 Diabetes

  2017cites this paper
• Diabetes status modifies the association between carotid intima-media thickness and incident heart failure: The Atherosclerosis Risk in Communities study.

  2017cites this paper
• Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes.

  2016cites this paper
• Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats

  2016cites this paper
• A Cross Sectional study on Diastolic Function and Factors Influencing Diastolic Function in Diabetes Mellitus Patients with Normal Systolic Function

  2016cites this paper
• Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy.

  2016influential citation
• Interactions between Diabetes and the Heart

  2016cites this paper
• Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart.

  2016cites this paper